FindTrial
Sign In

Acupuncture balanced anesthesia used in abdominal operation and its protective effects

Effects of transcutaneous electrical acupoint stimulation at different perioperative phases and at different frequencies on gastric-intestinal function in patients undergoing abdominal surgery: a multi-center randomized parallel controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004435
Enrollment
Unknown
Registered
2014-03-26
Start date
2014-06-02
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal disease

Interventions

1:TEAS at different perioperative phases
2:TEAS at different frequencies

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years old; 2. Consecutive patients undergoing elective abdominal surgery; 3. BMI 18-31kg/m2; 4. Patients with American Society of Anesthesiologists grading I-III; 5. Informed consent available.

Exclusion criteria

Exclusion criteria: 1. Scars or sensory impairments around the related acupoints; 2. Infections around the related acupoints; 3. Peripheral nerve injury; 4. History of Spinal surgery; 5. Participated in other clinical trials within four weeks; 6. Can not understand NRS scores or reject PCIA; 7. Patients with cardiac pacemaker; 8. Female in menstruation, pregnancy or lactation period; 9. Patients with preoperative pain or history of analgesics; 10. Patients with mental or neurological diseases. 11. Patients who need intraoperative colostomy; 12. Alcoholics; 13. Return to ICU; 14. Patients with allergies or history of steroids; 15. Develop serious intraoperative problems or complications(eg.bleeding,>2000ml) 16. Patients with history of liver or kidney disease; 17. Serum K+> 5.5mmol/L or <3.0mmol/L; 18. Preoperative hemoglobin<7g/dl; 19. Researchers considered unsuitable.

Design outcomes

Primary

MeasureTime frame
first Bowel sounds recovery time;first water intake time;first solid food intake time;the first flatus time;immune index;—

Secondary

MeasureTime frame
anesthetic induction drugs;anesthetic maintainence drugs;analgesic effect;immune index;PONV incidence;—

Countries

China

Contacts

Public ContactYi Feng

Peking University People's Hospital

yifeng65@sina.com+86 010 88325590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 2, 2026